Hydrolyzed aloe flower protein, preparation method thereof and application of hydrolyzed aloe flower protein in preparation of anti-glycosylation products

By processing aloe flowers, hydrolyzed aloe flower protein containing characteristic peptides was prepared, which solved the problem that existing technologies could not effectively utilize aloe flower protein, and achieved a significant improvement in AGEs inhibition rate and anti-glycation activity, which can be applied to anti-glycation products.

CN118978567AActive Publication Date: 2024-11-19完美(广东)日用品有限公司 +1
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411241663.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-19
Estimated Expiration
2044-09-05

AI Technical Summary

Technical Problem

Existing technologies cannot effectively extract and utilize protein substances from aloe vera flowers, especially their potential active protein sequences, resulting in low resource utilization.

Method used

By processing aloe flowers, aloe flower protein was extracted using the alkali dissolution and acid precipitation method, followed by proteolytic hydrolysis, ultrafiltration, and drying to prepare hydrolyzed aloe flower protein containing characteristic peptides, including characteristic peptides with amino acid sequences of Leu-Pro-Phe, Leu-Gly, and Ala-Phe.

Benefits of technology

Hydrolyzed aloe vera flower protein significantly improves the inhibition rate of AGEs, has anti-glycation activity, can protect protein substrates from glycation modification, and is safe for long-term use without side effects. It can be used in products for anti-glycation and related symptoms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978567A_ABST
    Figure CN118978567A_ABST
Patent Text Reader

Abstract

The invention relates to hydrolyzed aloe flower protein, a preparation method thereof and application of the hydrolyzed aloe flower protein in preparation of anti-glycosylation products, and belongs to the technical field of biology. The invention provides an aloe flower peptide. The aloe flower peptide comprises a characteristic peptide, wherein the amino acid sequence of the characteristic peptide is at least one of Leu-Pro-Phe, Leu-Gly and Ala-Phe. According to the invention, aloe flowers are treated to obtain the aloe flower peptide, and the aloe flower peptide is identified by HPLC-MS / MS to contain characteristic peptides of which the amino acid sequences are Leu-Pro-Phe, Leu-Gly and Ala-Phe. Experiments prove that both the aloe flower peptide and the hydrolyzed aloe flower protein containing the aloe flower peptide have the effect of improving the AGEs inhibition rate, and show that both the aloe flower peptide and the hydrolyzed aloe flower protein have anti-glycosylation activity, can protect a protein substrate from glycosylation modification, have the advantages of being safe, capable of being used for a long time, free of side effects and the like, and have good application prospects. The compound can be applied to products for resisting glycosylation and related symptoms thereof.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biotechnology, and in particular to a hydrolyzed aloe flower protein and a preparation method thereof and an application thereof in the preparation of an anti-glycosylation product. Background Art

[0002] Aloe vera, also known as shallot, is a perennial evergreen herbaceous plant of the genus Aloe in the Liliaceae family. There are many varieties of aloe vera, with nearly 400 known species and more than 500 varieties, mainly native to the Mediterranean coast and the arid tropical regions of southern Africa; it is also distributed in India and Malaysia in southern Asia. Aloe vera has high medicinal value, such as promoting wound healing, anti-ulcer, and laxative.

[0003] In recent years, with the deepening of research on aloe vera, the biological activity and material basis of aloe vera have been continuously revealed. In the application of aloe vera industry, aloe vera cosmetics have the most developed varieties, the best market acceptance and the greatest added value. As a natural moisturizer and skin nutrient, it can enhance skin metabolism, replenish skin moisture, prevent skin keratinization and maintain skin elasticity. It also has the functions of hair care, sterilization and itching, prevention of hair dryness and dandruff removal. At present, whitening creams, sunscreens, anti-wrinkle creams and facial masks made of aloe vera as raw materials use the natural moisturizing properties of aloe vera gel to maintain skin elasticity and luster, soften keratin, soothe the skin and prevent skin photoaging, meet the market demand for healthy and harmless skin care cosmetics with beauty and health functions, and show its unique industrial development advantages.

[0004] Although aloe vera and its extracts have been studied comprehensively, traditional extraction processes are unable to obtain the protein substances in aloe flowers, and the potential active protein sequences contained therein have not yet been identified and mined. Therefore, there is an urgent need to further develop the protein components in aloe flowers and their extract residues to improve the resource utilization of aloe flowers. Summary of the invention

[0005] The purpose of the present invention is to overcome the deficiencies of the prior art and provide a hydrolyzed aloe flower protein and a preparation method thereof and an application thereof in the preparation of an anti-glycosylation product.

[0006] To achieve the above object, the technical solution adopted by the present invention is:

[0007] In a first aspect, the present invention provides a hydrolyzed aloe flower protein comprising a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Gly and Ala-Phe.

[0008] The invention processes aloe flowers to obtain hydrolyzed aloe flower protein, and identifies the hydrolyzed aloe flower protein as containing characteristic peptides with amino acid sequences of Leu-Pro-Phe, Leu-Gly and Ala-Phe through HPLC-MS / MS.

[0009] As a preferred embodiment of the hydrolyzed aloe flower protein of the present invention, it comprises a characteristic peptide with the amino acid sequence of Leu-Pro-Phe, a characteristic peptide of Leu-Gly and a characteristic peptide of Ala-Phe.

[0010] Advanced glycation end products (AGEs) are compounds formed by non-enzymatic reactions between carbohydrates and biological molecules such as proteins, lipids or nucleic acids. These products usually accumulate under hyperglycemia and are closely related to aging and the development of various chronic diseases. AGEs not only affect protein structure and function, but also trigger inflammatory reactions by activating receptors, accelerating tissue damage and disease progression. Therefore, reducing the formation of AGEs is of great significance for maintaining health and preventing chronic diseases. The present invention experimentally confirms that aloe flower peptides and hydrolyzed aloe flower proteins containing aloe flower peptides have the effect of improving the AGEs inhibition rate, indicating that they all have anti-glycosylation activity, can protect protein substrates from glycosylation modification, and have the advantages of safety, long-term use, and no side effects, and can be applied to products for anti-glycosylation and its related symptoms.

[0011] As a preferred embodiment of the hydrolyzed aloe flower protein of the present invention, the mass ratio of the characteristic peptide Leu-Pro-Phe, the characteristic peptide Leu-Gly and the characteristic peptide Ala-Phe in the hydrolyzed aloe flower protein is Leu-Pro-Phe:Leu-Gly:Ala-Phe=(93.0-95.3):(1.0-1.7):(3.0-6.0).

[0012] In a second aspect, the present invention provides a method for preparing the hydrolyzed aloe flower protein, comprising the following steps:

[0013] (1) mixing aloe pollen with water, adjusting the pH to 10.0-11.0, extracting for 3 times, combining the extracts, and centrifuging to obtain a supernatant;

[0014] (2) adjusting the pH of the supernatant obtained in step (1) to 2.5-3.5, allowing it to stand, and centrifuging to obtain a precipitate;

[0015] (3) dissolving the precipitate obtained in step (2) in water, adjusting the pH to 6.0-8.0, adding protease, bathing at 45-55° C. for 4-6 hours, and centrifuging to obtain an enzymatic solution;

[0016] (4) ultrafiltration of the enzymatic hydrolyzate obtained in step (3) and drying to obtain hydrolyzed aloe flower protein.

[0017] The invention extracts aloe flower protein from aloe flower by alkali dissolution and acid precipitation method, and performs proteolysis, ultrafiltration and drying treatment on the aloe flower protein to prepare hydrolyzed aloe flower protein containing aloe flower peptides. The hydrolyzed aloe flower protein has excellent anti-glycosylation effect verified by in vivo and in vitro experiments. Different enzymolysis conditions (temperature, pH and enzymolysis time) will affect the generation of products, and then affect the activity of enzymolysis products. The invention verifies through experiments that the enzymolysis temperature is preferably 45-55°C, and the optimal temperature is 50°C; the enzymolysis pH is 6.0-8.0, and the optimal pH is 7.0; the enzymolysis time is 4-8h, and the optimal enzymolysis time is 4h.

[0018] As a preferred embodiment of the preparation method of the present invention, it includes at least one of the following (I) to (II):

[0019] (I) In step (1), the ratio of aloe pollen to water is aloe pollen: water = 1 g: (10-15) mL;

[0020] (II) In step (1), the extraction is performed in a water bath at 37°C for 40-60 minutes.

[0021] As a preferred embodiment of the preparation method of the present invention, it includes at least one of the following (III) to (IV):

[0022] (III) In step (3), the type of protease includes at least one of papain, trypsin, flavor protease and pepsin;

[0023] (IV) In step (3), the amount of protease added is 5500-6000U of protease per 1g of precipitation.

[0024] Generally, different proteases will produce different hydrolysis products when hydrolyzing the same substrate. On this basis, the present invention evaluates the difference in anti-glycosylation efficacy of hydrolyzed aloe flower protein prepared by different types of proteases through experiments. The results show that the hydrolyzed aloe flower protein obtained by using papain, trypsin, flavor protease and pepsin as proteases has excellent anti-glycosylation activity. Therefore, papain, trypsin, flavor protease and pepsin can be selected as proteases to prepare hydrolyzed aloe flower protein. In addition, the protease used in the enzymatic hydrolysis process of the preparation method of the present invention can be realized by a combination of multiple proteases, such as a combination of papain and trypsin, a combination of papain and flavor protease, a combination of papain and pepsin, and the like.

[0025] As a preferred embodiment of the preparation method of the present invention, in step (4), the ultrafiltration is to place the enzymatic hydrolyzate obtained in step (3) in an ultrafiltration membrane for ultrafiltration separation, and the molecular weight cutoff of the ultrafiltration membrane is 2500-3000Da.

[0026] The present invention has found through experiments that compared with unhydrolyzed aloe flower protein, the anti-glycosylation activity of hydrolyzed aloe flower protein is significantly increased, and the anti-glycosylation activity of hydrolyzed aloe flower protein with a molecular weight of less than 3000Da is better, which is related to the reduced molecular weight or the release of specific amino acid sequences.

[0027] As a preferred embodiment of the preparation method of the present invention, in step (1), the aloe pollen is prepared by naturally air-drying the aloe flowers, crushing them and passing them through a 40-mesh sieve to obtain the aloe pollen.

[0028] As a preferred embodiment of the preparation method of the present invention, in step (1), the raw material of the aloe pollen includes whole aloe flowers, and residues produced by aloe flowers used in the preparation of essences, essential oils or extracts.

[0029] In a third aspect, the present invention provides an aloe flower peptide, wherein the aloe flower peptide is composed of a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Gly and Ala-Phe.

[0030] In a fourth aspect, the present invention provides the use of the aloe flower peptide or hydrolyzed aloe flower protein in the preparation of an anti-glycosylation product.

[0031] The aloe flower peptide and hydrolyzed aloe flower protein provided by the present invention can inhibit the formation of AGEs and also have a significant inhibitory effect on the inflammatory response induced by AGEs, and can significantly reduce the release of inflammatory mediators induced by AGEs, such as TNF-α and IL-6, thereby alleviating inflammatory damage to body tissues and organs. Therefore, the aloe flower peptide and hydrolyzed aloe flower protein provided by the present invention have the dual effects of inhibiting the formation of AGEs and AGEs-induced inflammation, and have obvious advantages in anti-glycosylation products.

[0032] As a preferred embodiment of the application of the present invention, the products include medicines, foods, health products, cosmetics and biological products.

[0033] As a preferred embodiment of the application of the present invention, the dosage of the hydrolyzed aloe flower protein is 250-1000 mg per 1 kg body weight of the organism.

[0034] In a fourth aspect, the present invention provides an anti-glycosylation cosmetic comprising the above-mentioned aloe flower peptide or hydrolyzed aloe flower protein.

[0035] Compared with the prior art, the present invention has the following beneficial effects:

[0036] 1. The present invention obtains hydrolyzed aloe flower protein by treating aloe flower, and identifies the aloe flower peptides containing characteristic peptides with amino acid sequences of Leu-Pro-Phe, Leu-Gly and Ala-Phe by HPLC-MS / MS.

[0037] 2. The present invention has experimentally confirmed that aloe flower peptides and hydrolyzed aloe flower proteins containing aloe flower peptides have the effect of increasing the AGEs inhibition rate, indicating that they both have anti-glycosylation activity, can protect protein substrates from glycosylation modification, and have the advantages of safety, long-term use, and no side effects. They can be applied to products for anti-glycosylation and its related symptoms.

[0038] 3. The present invention extracts aloe flower protein from aloe flowers by alkali dissolution and acid precipitation method, and performs proteolysis, ultrafiltration and drying treatment on the aloe flower protein to prepare hydrolyzed aloe flower protein containing aloe flower peptides. In vivo and in vitro experiments verify that the hydrolyzed aloe flower protein has excellent anti-glycosylation effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 This is the liquid-to-water BPC diagram of hydrolyzed aloe flower protein in Example 1 of the present invention;

[0040] Figure 2 The secondary mass spectrum of the LPF peptide segment in Example 1 of the present invention;

[0041] Figure 3 The secondary mass spectrum of the LG peptide segment in Example 1 of the present invention;

[0042] Figure 4 This is the secondary mass spectrum of the AF peptide segment in Effect Example 1 of the present invention. DETAILED DESCRIPTION

[0043] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0044] Unless otherwise specified, other materials, reagents, etc. used in the examples can be obtained from commercial sources.

[0045] The aloe species used in the aloe flower peptide and the hydrolyzed aloe flower protein of the present invention are not limited. The aloe used in the following examples and comparative examples is Aloe vera.

[0046] The ultrafiltration membrane was purchased from Suez Environment Group, made of TFM, with a molecular weight cutoff of 3000Da.

[0047] Human fibroblasts were purchased from the Chinese Science Cell Bank with the catalog number GNHu49. The cell culture conditions were based on the description of human fibroblasts in the Chinese Science Cell Bank.

[0048] The solid phase synthesis of LPF, LG and AF characteristic peptides is commissioned to a biological company. The commissioned biological company only needs to have the qualification to synthesize peptides, without any restrictions.

[0049] SPF female BALB / c mice were purchased from Guangdong Medical Experimental Animal Center (SCXK (Yue) 2022-0002).

[0050] SPF-grade Kunming female mice were purchased from Guangdong Medical Experimental Animal Center (SCXK (Yue) 2022-0002).

[0051] The ELISA kit for AGEs was purchased from Beijing Myrida Technology Co., Ltd. with the catalog number M150216-96T.

[0052] The IL-6 ELISA kit was purchased from Beijing Merida Technology Co., Ltd. with the catalog number MF01310-96T.

[0053] The ELISA kit for TNF-α was purchased from Beijing Merida Technology Co., Ltd. with the catalog number MF02810-48T.

[0054] The techniques not described in detail in the following embodiments, comparative examples and effect examples are all commonly used techniques in the art, and reference may be made to "Handbook of Molecular Biology Experiments" (Ma Wenli, People's Military Medical Publishing House), "Molecular Biology Experiments (Second Edition)" (Zhejiang University Press), and "Cell Biology Experiments" (Yang Hongbing, Hou Lixia, Zhang Yuxi, Higher Education Press).

[0055] In the following embodiments and effect examples, "V" refers to valine (Val), "P" refers to proline (Pro), "G" refers to glycine (Gly), "H" refers to histidine (His), "R" refers to arginine (Arg), "K" refers to lysine (Lys), "I" refers to isoleucine (Ile), "F" refers to phenylalanine (Phe), "L" refers to leucine (Leu), "W" refers to tryptophan (Trp), "A" refers to alanine (Ala), "M" refers to methionine (Met), "C" refers to cysteine ​​(Cys), "N" refers to asparagine (Asn), "S" refers to serine (Ser), "Q" refers to glutamine (Gln), "Y" refers to tyrosine (Tyr), "D" refers to aspartic acid (Asp), "E" refers to glutamic acid (Glu), and "T" refers to threonine (Thr).

[0056] In the following examples, comparative examples and effect examples, LPF refers to Leu-Pro-Phe characteristic peptide, LG refers to Leu-Gly characteristic peptide, and AF refers to Ala-Phe characteristic peptide.

[0057] Example 1

[0058] This embodiment provides a hydrolyzed aloe flower protein and a preparation method thereof, the preparation method comprising the following steps:

[0059] S1, aloe vera flowers are naturally air-dried, crushed and passed through a 40-mesh sieve to obtain aloe vera pollen;

[0060] S2, taking the aloe pollen obtained in step S1 and mixing it with water according to the ratio of aloe pollen: water = 1 g: 10 mL, adjusting the pH to 11.0 with 2M NaOH solution, extracting in a 37°C water bath for 40 min, repeating the extraction 3 times, combining the 3 extracts, centrifuging at 10000 rpm for 10 min, and obtaining a supernatant;

[0061] S3, adjusting the pH of the supernatant obtained in step S2 to 3.0 using a 2M HCl solution, allowing the solution to stand for precipitation, and centrifuging at 10000 rpm for 10 min to obtain a precipitate, wherein the precipitate is crude protein;

[0062] S4, adding water to the precipitate obtained in step S3, adding 10 mL of water for every 1 g of precipitate, stirring evenly, adjusting pH to 7.0 with 2M NaOH solution, placing in a water bath at 50°C, adding 6000 U of papain for every 1 g of precipitate, stirring at 300 rpm for enzymolysis for 4 h, placing in a water bath at 90°C for 15 min after enzymolysis, cooling to room temperature, centrifuging at 10000 rpm for 10 min, collecting the supernatant, and the obtained supernatant is the enzymolysis solution;

[0063] S5. The enzymatic hydrolyzate obtained in step S4 is ultrafiltered using a laboratory membrane separation device (Hefei Wo Teng Membrane Separation Equipment Co., Ltd.), and the ultrafiltration membrane used has a molecular weight cutoff of 3000Da, to obtain an ultrafiltration solution with a molecular weight lower than 3000Da, and the ultrafiltration solution is spray-dried in a high-speed centrifugal spray dryer to obtain hydrolyzed aloe flower protein, wherein the hydrolyzed aloe flower protein contains aloe flower peptides.

[0064] Example 2-3

[0065] Examples 2-3 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, the preparation method is similar to that of Example 1, except that:

[0066] Example 2: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 45° C.”, and the other operations remain unchanged;

[0067] Example 3: In step S4, the "placed in a water bath at 50°C" is adjusted to "placed in a water bath at 55°C", and the other operations remain unchanged.

[0068] Embodiment 4-5

[0069] Examples 4-5 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, and the preparation method is similar to that of Example 1, except that:

[0070] Example 4: In step S4, the step of "adjusting pH=7.0 with 2M NaOH solution" is adjusted to "adjusting pH=6.0 with 2M NaOH solution", and the other operations remain unchanged;

[0071] Example 5: In step S4, the "adjusting pH=7.0 with 2M NaOH solution" is adjusted to "adjusting pH=8.0 with 2M NaOH solution".

[0072] Embodiment 6-9

[0073] Examples 6-9 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, and the preparation method is similar to that of Example 1, except that:

[0074] Example 6: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 5 h", and the other operations remain unchanged;

[0075] Example 7: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 6 h", and the other operations remain unchanged;

[0076] Example 8: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 7 h", and the other operations remain unchanged;

[0077] Example 9: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 8 h", and the other operations remain unchanged.

[0078] Examples 10-12

[0079] Examples 10-12 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, and the preparation method is similar to that of Example 1, except that:

[0080] Example 10: In step S4, the step of “adding 6000U papain per 1g of precipitate” is adjusted to “adding 6000U trypsin per 1g of precipitate”, and the other operations remain unchanged;

[0081] Example 11: In step S4, the step of “adding 6000U papain per 1g of precipitate” is adjusted to “adding 6000U flavor protease per 1g of precipitate”, and the other operations remain unchanged;

[0082] Example 12: In step S4, the step of “adding 6000 U of papain per 1 g of precipitate” is adjusted to “adding 6000 U of pepsin per 1 g of precipitate”, and the other operations remain unchanged.

[0083] Comparative Examples 1-4

[0084] Comparative Examples 1-4 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0085] Comparative Example 1: In step S4, the “adding 6000 U / g of papain” was adjusted to “adding 6000 U / g of alkaline protease”, and the other operations remained unchanged;

[0086] Comparative Example 2: In step S4, the “add 6000U papain per 1g of precipitate” is adjusted to “add 6000U neutral protease per 1g of precipitate”, and the other operations remain unchanged;

[0087] Comparative Example 3: In step S4, the step of “adding 6000U papain per 1g of precipitate” was adjusted to “adding 6000U composite protease per 1g of precipitate”, and the other operations remained unchanged;

[0088] Comparative Example 4: In step S4, the “add 6000U papain per 1g of precipitation” is adjusted to “add 6000U bromelain per 1g of precipitation”, and the other operations remain unchanged.

[0089] Comparative Examples 5-8

[0090] Comparative Examples 5-8 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0091] Comparative Example 5: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 30° C.”, and the other operations remain unchanged;

[0092] Comparative Example 6: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 35° C.”, and the other operations remain unchanged;

[0093] Comparative Example 7: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 40° C.”, and the other operations remain unchanged;

[0094] Comparative Example 8: In step S4, the “placed in a water bath at 50°C” is adjusted to “placed in a water bath at 60°C”, and the other operations remain unchanged.

[0095] Comparative Examples 9-11

[0096] Comparative Examples 9-11 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0097] Comparative Example 9: In step S4, the step of "adjusting pH=7.0 with 2M NaOH solution" is adjusted to "adjusting pH=5.0 with 2M NaOH solution", and the other operations remain unchanged;

[0098] Comparative Example 10: In step S4, the “adjusting pH=7.0 with 2M NaOH solution” is adjusted to “adjusting pH=9.0 with 2M NaOH solution”;

[0099] Comparative Example 11: In step S4, the “adjusting pH=7.0 with 2M NaOH solution” is adjusted to “adjusting pH=10.0 with 2M NaOH solution”.

[0100] Comparative Examples 12-14

[0101] Comparative Examples 12-14 respectively provide a hydrolyzed aloe flower protein and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0102] Comparative Example 12: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" was adjusted to "enzymolysis with stirring at 300 rpm for 1 h", and the other operations remained unchanged;

[0103] Comparative Example 13: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" was adjusted to "enzymolysis with stirring at 300 rpm for 2 h", and the other operations remained unchanged;

[0104] Comparative Example 14: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 3 h", and the other operations remain unchanged.

[0105] Comparative Example 15

[0106] Comparative Example 15 provides a hydrolyzed aloe leaf protein and a preparation method thereof, the preparation method is similar to that of Example 1, except that:

[0107] In step S1, the "aloe flower" is replaced with "aloe leaf";

[0108] In step S5, the spray drying process is adjusted to freeze drying, and the remaining steps and parameter conditions remain unchanged.

[0109] Effect Example 1

[0110] The hydrolyzed aloe flower protein obtained in Example 1 and the hydrolyzed aloe leaf protein obtained in Comparative Example 15 were characterized, and the specific scheme is as follows:

[0111] 1. Determination of amino acid composition in hydrolyzed aloe flower protein and hydrolyzed aloe leaf protein.

[0112] With reference to the national safety standard GB 5009.124-2016 Determination of amino acids in food, the amino acid content of the hydrolyzed aloe flower protein prepared in Example 1 was analyzed using an S7130 amino acid automatic analyzer (SYKAM, Germany), with a separation column of Cation Separation Column LCA K06 / Na, 150 mm×4.6 mm; and an ammonia removal column of Ammonia Filtration Column LCA K04 / Na, 100 mm×4.6 mm. The measurement results are shown in Table 1.

[0113] Table 1 Amino acid content of hydrolyzed aloe flower and hydrolyzed aloe leaf proteins

[0114]

[0115] As shown in Table 1, glutamic acid, serine, etc. are the main amino acids in hydrolyzed aloe flower protein, followed by aspartic acid and leucine. The acidic amino acid content of the protein extracted from the flower of Aloe vera is relatively high, indicating that the flower protein of Aloe vera is acidic under natural conditions, which is consistent with its isoelectric point result. The amino acid composition of hydrolyzed aloe leaf protein is different from that of hydrolyzed aloe flower protein, such as the percentage of serine and glycine is lower than that of hydrolyzed aloe flower protein, and the percentage of arginine and tyrosine is higher than that of hydrolyzed aloe flower protein, indicating that there are certain differences in the proteins extracted from different parts of aloe.

[0116] 2. The peptide sequence of the hydrolyzed aloe flower protein obtained in Example 1 was identified.

[0117] The amino acid sequence of the hydrolyzed aloe flower protein prepared in Example 1 was identified using the HPLC-MS / MS method. The specific detection method is as follows:

[0118] The samples were separated and detected using an X500 LC-ESI-Q-TOF high-resolution liquid chromatography-mass spectrometer (AB SCIEX, USA). The liquid chromatography and mass spectrometry control software used was SCIEX OS2.0 integrated version (AB SCIEX, USA); the chromatographic column used was 1×100mm HSS T3 (1.8μm, Waters, USA).

[0119] The mobile phase consisted of 0.1% (v / v) formic acid aqueous solution (A) and acetonitrile (B), and the elution method was: 0-4.00min 5.0% B, 4.00-6.00min 5.0-10.0% B, 6.00-30.00min 10.0-40.0% B, 30.00-34.00min 40.0-90.0% B, 34.00-40.00min 90% B, 40.00-42.00min 90.0-5.0% B, 42.00-52.00min 5.0% B, flow rate 0.05mL / min, injection volume 1μL, column temperature 40°C, the percentages of the above mobile phases mean volume percentages, volume of mobile phase B / total volume of mobile phase A and mobile phase B.

[0120] Mass spectrometry detection method: scanning cycle 0.642s, ESI ion source temperature 500℃, positive ion mode, spray voltage 5500V, TOF primary scanning range 100-1200Da, secondary scanning range 50-1200Da, working mode IDA, maximum candidate ion number 4, dynamic exclusion turned on, and the rest of the parameters used the default values ​​of the proteomics method. Note that the dead volume should be minimized before using the instrument. The identification results are shown in Figure 1-4 and Table 2.

[0121] Table 2 Identification results of aloe flower peptide sequences in hydrolyzed aloe flower proteins

[0122]

[0123] like Figure 1-4 As shown in Table 2, the present invention uses HPLC-MS / MS technology to identify three characteristic amino acid sequences from hydrolyzed aloe flower protein, including two dipeptides (LG, AF) and one tripeptide (LPF).

[0124] Effect Example 2

[0125] The anti-glycosylation (AGEs) activity of the hydrolyzed aloe flower protein obtained in Example 1 was evaluated, and the specific scheme is as follows:

[0126] This effect example selected the crude protein obtained in step S3 of Example 1, the enzymatic hydrolysate obtained in step S4 of Example 1, the components >3000Da and <3000Da obtained in step S5 of Example 1, and the LPF, LG, and AF characteristic peptides synthesized by solid phase for experiment.

[0127] A reaction solution containing bovine serum albumin (BSA, 2.8 mg / mL) and methylglyoxal (1 mmol / L) was prepared with PBS. 1 mL of the reaction solution and 1 mL of the sample solution (the sample concentrations of aloe flower protein, enzymatic hydrolysate, components less than 3000 Da and components greater than 3000 Da were 2 mg / mL, respectively; the sample concentrations of LPF, LG, and AF were 0.5 mM, respectively) were completely mixed in a glass test tube, and the bottle mouth was sealed with a sealing film, and placed in a constant temperature incubator at 37°C for 7 days to react to form a glycosylated albumin complex (AGEs-BSA).

[0128] At the same time, 1 mL of the reaction solution was mixed with 1 mL of PBS solution as a blank control group. AGEs-BSA has characteristic fluorescence absorption characteristics (excitation wavelength 370 nm, emission wavelength 450 nm). The generation level of AGEs-BSA was determined by fluorescence spectroscopy and calculated using the following formula. The results are shown in Table 3:

[0129] AGEs-BSA inhibition rate (%) = [1-(A sample / A blank)] × 100%

[0130] Wherein, Asample: the absorbance value of the sample, Ablank: the absorbance value of the blank control.

[0131] Table 3 AGEs-BSA inhibition rate in different treatment groups

[0132] Group AGEs-BSA inhibition rate (%) Example 1 Crude Protein 15.6 Example 1 Enzyme hydrolysate 31.2 Example 1 Components less than 3000Da 52.1 Example 1 Components greater than 3000Da 20.9 LPF 48.3 LG 42.7 AF 44.6 Comparative Example 15 Aloe leaf crude protein 3.2 Comparative Example 15 Enzyme Hydrolysate 6.7 Comparative Example 15 Components less than 3000Da 11.9 Comparative Example 15 Components greater than 3000Da 8.5

[0133] As shown in Table 3, although the crude protein of aloe flower itself has a certain anti-glycosylation effect, its activity is significantly improved after enzymatic hydrolysis, and the AGEs-BSA inhibition rate increases from 15.6% to 31.2%, while the AGEs-BSA inhibition rate of the hydrolyzed aloe flower protein with a molecular weight less than 3000Da can reach more than 50%. It can be seen that the hydrolyzed aloe flower protein containing low molecular weight is obtained by enzymatic hydrolysis and ultrafiltration, which significantly improves the performance and functional value of the aloe flower protein. The three characteristic peptides (LPF, LG, AF) in the hydrolyzed aloe flower protein also have strong anti-glycosylation activity, and the AGEs-BSA inhibition rate is more than 40%. Compared with aloe flower, the AGEs-BSA inhibition rate of aloe leaf protein and its enzymatic hydrolysate is relatively low, all below 10%, and the AGEs-BSA inhibition rate of its component less than 3000Da is only 11.9%, indicating that the effect is far inferior to the hydrolyzed aloe flower protein of the present invention.

[0134] Effect Example 3

[0135] The anti-glycosylation activity of the hydrolyzed aloe flower proteins obtained in Examples 1-10 and Comparative Examples 1-14 was tested, and the AGEs-BSA inhibition rate was tested according to the method of Effect Example 2. The results are shown in Table 4.

[0136] Table 4 Effects of different enzymatic hydrolysis processes on the anti-glycosylation activity of hydrolyzed aloe flower protein

[0137]

[0138] As shown in Table 4, the anti-glycosylation activity of hydrolyzed aloe flower proteins prepared by different processes is different. The anti-glycosylation activity of hydrolyzed aloe flower proteins prepared by different proteases is quite different, and the activity is papain (52.1%), flavor protease (40.5%), trypsin (36.1%), pepsin (35.2%), composite protease (33.4%), neutral protease (28.9%), bromelain (25.3%), and alkaline protease (19.2%). Therefore, papain is preferably used in the present invention to prepare the anti-glycosylation aloe flower peptide.

[0139] In addition to proteases, the temperature, pH value and time of enzymatic hydrolysis also have a certain influence on the anti-glycation activity of hydrolyzed aloe flower protein. Through experiments, it was found that the anti-glycation activity of the product was better when the enzymatic hydrolysis temperature was controlled in the range of 45-55℃, among which 50℃ was the best; the anti-glycation activity of the product was better when the enzymatic hydrolysis pH was in the range of 6.0-8.0, among which 7.0 was the best; the anti-glycation activity of the product was better when the enzymatic hydrolysis time was in the range of 4-8h, and the enzymatic hydrolysis time was 4h.

[0140] Effect Example 4

[0141] The effect of the hydrolyzed aloe flower protein obtained in Example 1 on AGEs in the skin tissue of a skin aging mouse model was tested. The specific scheme is as follows:

[0142] 6-week-old SPF female BALB / c female mice (18-22g) were adaptively raised in an environment with an ambient temperature of 20-25°C, a humidity of 40%-60%, and a daily light of 12h (7:00-19:00) for one week before conducting the experiment. All mice were randomly divided into a normal control group, a D-galactose model group, a low-dose (250mg / kg) group of hydrolyzed aloe flower protein, a medium-dose (500mg / kg) group of hydrolyzed aloe flower protein, and a high-dose (1000mg / kg) group of hydrolyzed aloe flower protein, with 8 mice in each group. Except for the normal control group, the mice in the other groups were subcutaneously injected with D-galactose (500mg / kg) at the nape of the neck to prepare a subacute skin aging model, once a day for 8 consecutive weeks. Since the modeling date, the mice in the drug administration group were gavaged with the hydrolyzed aloe flower protein prepared in Example 1 every day, and the normal control group and the model group were gavaged with an equal volume of normal saline. After the experiment, the mice were killed by dislocating the neck, the hair on the back was cut, the back skin was collected, the subcutaneous tissue was removed, and the skin was stored in a -80°C refrigerator.

[0143] Cut the mouse skin tissue into small pieces, add an appropriate amount of liquid nitrogen to harden the tissue, and crush the tissue with a mortar. Add RIPA protein lysis buffer, use an automatic homogenizer to homogenize for 2 minutes, place on ice to continue lysis for 30 minutes, centrifuge at 12000r / min for 10 minutes at 4℃, collect the supernatant, and use an ELISA kit to detect the content of AGEs.

[0144] Table 5 Levels of AGEs in skin tissues of aged mice in different treatment groups

[0145]

[0146] As shown in Table 5, compared with the normal control group mice, the level of AGEs in the skin tissue of the D-galactose skin aging model group mice was significantly increased, indicating a higher level of glycosylation modification in the skin tissue, and aloe flower peptides can significantly reduce the AGEs content in the skin of aged mice, which suggests that the aloe flower peptides provided by the present invention can inhibit the formation of AGEs in vivo and reduce their glycosylation modification and functional damage to biological molecules in skin tissue.

[0147] Effect Example 5

[0148] The effect of the hydrolyzed aloe flower protein obtained in Example 1 on AGEs in the tissues and organs of the diabetic mouse model was detected. The specific scheme is as follows:

[0149] Six-week-old SPF Kunming female mice (18-22g) were adaptively raised for one week in an environment with an ambient temperature of 20-25°C, a humidity of 40%-60%, and a daily light of 12h (7:00-19:00) before the experiment was carried out. Mice were intraperitoneally injected with 1wt% streptozotocin (STZ) solution (40mg / kg) after fasting for 12h for 5 consecutive days, and 10wt% sucrose was added to the drinking water during the modeling period. The fasting blood glucose of mice was measured 3 weeks after the first injection of STZ, and when the fasting blood glucose was higher than 11.1mmol / L, it was considered that the hyperglycemia model was successfully established.

[0150] The mice were randomly divided into a normal control group, a model control group, a low-dose (250 mg / kg) hydrolyzed aloe flower protein group, a medium-dose (500 mg / kg) hydrolyzed aloe flower protein group, and a high-dose (1000 mg / kg) hydrolyzed aloe flower protein group, with 8 mice in each group. Except for the normal control group, the mice in the remaining groups were given hydrolyzed aloe flower protein by gavage every day, once a day, for 6 consecutive weeks, and the normal control group and the model group were given an equal volume of normal saline. After the experiment, the mice were killed by dislocation of the neck, the back hair was cut off, the back skin was collected, the subcutaneous tissue was removed, and the eyeballs, kidneys, heart, liver and other tissues were collected and placed in a -80°C refrigerator for storage. The level of AGEs in various organs of the mice was detected according to the method described in Example 4, and the results are shown in Table 6.

[0151] Table 6 Levels of AGEs in various organs of diabetic mice

[0152]

[0153] As shown in Table 6, compared with the normal control group mice, the levels of AGEs in the skin tissue, eyes, kidneys, heart, liver and other tissues of the model control group mice were significantly increased, while the hydrolyzed aloe flower protein could significantly reduce the AGEs in these tissues and organs. These results indicate that the hydrolyzed aloe flower protein provided by the present invention can alleviate the glycated damage of multiple tissues and organs of the body under high sugar environment, and is expected to prevent and treat a variety of diabetic complications.

[0154] Effect Example 6

[0155] AGEs not only affect the structure and function of proteins by cross-linking and damaging them, but also activate inflammatory responses. The combined effects of these two have a significant impact on the body. Studies have shown that AGEs activate multiple inflammatory signaling pathways by binding to their receptors, such as RAGE, leading to the release of inflammatory mediators, which in turn damage the health of cells and tissues. Therefore, this effect example evaluates the effect of the hydrolyzed aloe flower protein obtained in Example 1 on AGEs-induced inflammatory responses. The specific scheme is as follows:

[0156] Human fibroblasts were plated in a 96-well plate. After the cells adhered overnight, AGEs and the hydrolyzed aloe flower protein obtained in Example 1 were simultaneously administered to the cells. The final concentrations were set to three doses of 25 μg / mL, 50 μg / mL and 100 μg / mL, respectively. After 48 hours, the culture supernatant was collected and the levels of IL-6 and TNF-α therein were detected by ELISA. The results are shown in Table 7.

[0157] Table 7 Levels of inflammatory factors in the supernatants of cell culture treated with different

[0158]

[0159] As shown in Table 7, compared with the blank control group, AGEs can significantly promote the release of IL-6 and TNF-α from human skin fibroblasts, while hydrolyzed aloe flower protein can significantly reduce the level of inflammatory factors, thereby eliminating further tissue damage caused by AGEs through inflammation induction.

[0160] In summary, the hydrolyzed aloe flower protein provided by the present invention has dual effects, which can not only inhibit the formation of AGEs, but also alleviate the inflammatory storm induced by AGEs, reflecting a comprehensive anti-glycosylation effect.

[0161] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A hydrolyzed aloe flower protein, characterized in that: The invention comprises a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Gly and Ala-Phe.

2. The hydrolyzed aloe flower protein according to claim 1, characterized in that: The invention comprises a characteristic peptide with the amino acid sequence of Leu-Pro-Phe, a characteristic peptide of Leu-Gly and a characteristic peptide of Ala-Phe.

3. The hydrolyzed aloe flower protein according to claim 1, characterized in that: The mass ratio of the characteristic peptide Leu-Pro-Phe, the characteristic peptide Leu-Gly and the characteristic peptide Ala-Phe in the hydrolyzed aloe flower protein is Leu-Pro-Phe:Leu-Gly:Ala-Phe=(93.0-95.3):(1.0-1.7):(3.0-6.0).

4. The method for preparing hydrolyzed aloe flower protein according to claim 1, characterized in that: The following steps are involved: (1) mixing aloe pollen with water, adjusting the pH to 10.0-11.0, extracting three times, combining the extracts, and centrifuging to obtain a supernatant; (2) adjusting the pH of the supernatant obtained in step (1) to 2.5-3.5, allowing it to stand, and centrifuging it to obtain a precipitate; (3) dissolving the precipitate obtained in step (2) in water, adjusting the pH to 6.0-8.0, adding protease, bathing at 45-55° C. for 4-6 hours, and centrifuging to obtain an enzymatic solution; (4) ultrafiltration of the enzymatic hydrolyzate obtained in step (3) and drying to obtain hydrolyzed aloe flower protein.

5. The preparation method according to claim 4, characterized in that: Including at least one of the following (I) to (II): (I) In step (1), the ratio of aloe pollen to water is aloe pollen: water = 1 g: (10-15) mL; (II) In step (1), the extraction is performed in a water bath at 37°C for 40-60 minutes.

6. The preparation method according to claim 4, characterized in that: Including at least one of the following (III) to (IV): (III) in step (3), the type of protease includes at least one of papain, trypsin, flavor protease and pepsin; (IV) In step (3), the amount of protease added is 5500-6000U of protease per 1g of precipitation.

7. The preparation method according to claim 4, characterized in that: In step (4), the ultrafiltration is to place the enzymatic hydrolysate obtained in step (3) in an ultrafiltration membrane for ultrafiltration separation, and the cut-off molecular weight of the ultrafiltration membrane is 2500-3000Da.

8. An aloe flower peptide, characterized in that: The aloe flower peptide is composed of a characteristic peptide whose amino acid sequence is at least one of Leu-Pro-Phe, Leu-Gly and Ala-Phe.

9. Use of the hydrolyzed aloe flower protein according to any one of claims 1 to 3 or the aloe flower peptide according to claim 8 in the preparation of an anti-glycosylation product.

10. An anti-glycation cosmetic, characterized in that: It comprises the hydrolyzed aloe flower protein as described in any one of claims 1 to 3 or the aloe flower peptide as described in claim 8.

Citation Information

Patent Citations

  • Preparation method and application for aloe flower extracting solution

    CN111759779A

  • Composition containing aloe active compound and preparation method and application thereof

    CN114272190A

  • Composition comprising aloe flower extracts for antioxidant, antiinflammatory or immunomodulatory effect

    KR1020150130207A

  • Composition for moisturizing skin, promoting skin regeneration, and treating wounds, comprising aloe vera flower extract, or aloe vera flower extract and aloe vera polysaccharides, as active ingredient(s)

    WO2022250313A1

  • KR20220160177A